Background Papillary thyroid cancer (PTC) has an excellent prognosis with current
treatment methods. However, the rates of locoregional recurrence after initial surgical …

Aim The aim of this study was to assess the efficacy of treatment of patients with papillary
thyroid carcinoma (PTC) and lymph node metastases at the time of diagnosis and its …

In the management of papillary thyroid cancer (PTC), surgery is indicated for locoregional
recurrent/persistent disease. In this study, we examined the effect of such surgery on serum …

Background The clinical outcomes of delayed radioiodine remnant ablation (RRA) therapy
in patients with low-risk papillary thyroid carcinoma (PTC) are unclear. We aimed to evaluate …

Background: Persistent or recurrent papillary thyroid carcinoma (PTC) occurs in some
patients after initial thyroid surgery and often, radioactive iodine treatment. Here, we identify …

Importance One-third of patients with papillary thyroid cancer (PTC) develop persistent or
recurrent disease after initial therapy. Most patients with persistent or recurrent disease …

Context: The primary treatment of locoregionally recurrent/persistent papillary thyroid cancer
(PTC) is surgical removal by reoperation. However, there had been only limited number of …

Introduction: Papillary and follicular thyroid carcinomas are the most common thyroid
malignancies and are usually indolent. Lymph-node involvement increases the rate of tumor …

Multiple prognostic factors for outcome in papillary thyroid carcinoma are identified. For a
cohort of 1500 consecutive patients followed an average of 16 years, survival rates for tumor …

We have analyzed the course of papillary thyroid carcinoma in 269 patients managed at the
University of Chicago, with an average follow-up period of 12 yr from the time of diagnosis …